Valeant defends against allegations

Valeant Pharmaceuticals International Inc. (NYSE: VRX) defended itself against allegations of questionable business practices but the stock price continued to fall by plunging $6.12 to close at $110.04.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.